The Neighborhoods Study: Adverse Social Exposome and Alzheimer’s Disease and Related Dementias (ADRD)
Funded Grant
Overview
Affiliation
View All
Overview
description
Alzheimer's disease and related dementias (ADRD) disproportionately impact populations exposed to adverse social exposome (i.e., socioeconomic contextual life-course) factors, yet the sociobiological mechanistic underpinnings of this risk are only partially known. Deep precision phenotypic evaluation of populations at greater ADRD risk fundamentally increases opportunity for discovery of novel mechanistic pathways and development of new and effective ADRD prevention strategies. Since most specific ADRD neurodegenerative diseases can only be diagnosed through examination of post-mortem tissue, and brain bank repositories with such tissue rarely offer linkage to deep social exposome phenotyping, progress has been limited. We have begun to address this critical gap through the Neighborhoods Study (R01AG070883), a unique collaboration first funded by the NIA in 2021. Incorporating 21 Alzheimer's Disease Research Center (ADRC) brain banks, the Neighborhoods Study is the largest study of its kind, linking life-course social exposome measures— including the Area Deprivation Index (ADI, metrics built 1910-present by our team)— to neuropathology (N=8,637), uniquely providing insights into the many ADRD neurodegenerative diseases that can only be diagnosed from brain tissue. This ADI— built, validated and updated annually by our team— incorporates poverty, education, housing and employment indicators and is a widely used measure of the social exposome. In the first funding period, we built unique infrastructure, grew the ADRD exposome research community, and derived residential histories to establish dosage and timing of ADI exposure across each life-course. The Neighborhoods Study has catalyzed the field through its innovative findings to date, including demonstrating that even after adjustment for individual risk factors, high ADI is strongly associated with cognitive function, neurodegeneration, AD biomarkers and post- mortem AD neuropathology; that high ADI exposure carries markedly increased odds of post-mortem limbic- predominant age-related TDP-43 encephalopathy (LATE) and Lewy body neuropathology; and that living in a high ADI neighborhood across the life-course increases risk of cerebrovascular neuropathology over eight-fold. Mechanistic underpinnings for these associations remain unknown but could be linked to toxic heavy metal and high-risk occupational exposures (e.g., agriculture, military, factory) more common in high ADI areas. Exposure to such factors is known to increase clinical dementia diagnosis risk, but the precise neuropathology and life- course windows of susceptibility remain unknown. Thus, a path to precision prevention and risk mitigation remains elusive. To better understand these mechanisms, we propose a renewal that further enriches the cohort and offers novel exposome measures including life-course assessment of lead-laced infrastructure exposure; life-course occupational history construction; and brain tissue measures of heavy metals. The proposed project leverages the majority of ADRCs to further broaden understanding of how adverse social exposome impacts ADRD risk, providing a potential pathway to new interventions and directly responsive to the NIA mission.